PLK1 has been reported to be over-expressed in numerous cancer types, such as non-small-cell lung cancer, oropharyngeal carcinoma, esophageal carcinoma, melanoma, colorectal cancer, hepatoblastoma, non-Hodgkin lymphoma, and others [12]. This evidence concerns the gene PLK1 and hepatoblastoma.